CAMBRIDGE, Mass.--(BUSINESS WIRE)--BIND Biosciences announced today that it has been awarded a prestigious 2011 Edison Best New Product in Science and Medicine Game Changers Award. This award recognizes BIND’s innovative targeted nanoparticle therapeutic platform for its potential to revolutionize the treatment of many serious diseases. The Edison Awards symbolize the persistence and excellence personified by Thomas Alva Edison, inspiring America’s drive to remain in the forefront of innovation, creativity and ingenuity in the global economy.
